ArticleLeukemia2024

Combination therapies with ponatinib and asciminib in a preclinical model of chronic myeloid leukemia blast crisis with compound mutations.

Nikola Curik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.